Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Acrux ( (AU:ACR) ) has shared an announcement.
Acrux Limited has announced its Annual General Meeting (AGM) scheduled for November 25, 2025, where shareholders will discuss key resolutions including the re-election of Dr. Geoff Brooke as a director, the issuance of rights to non-executive directors, and options to the CEO under the company’s Omnibus Equity Plan. Additionally, shareholders will consider approving a 10% placement capacity for equity securities, which could impact the company’s capital structure and shareholder value.
More about Acrux
Acrux Limited is a company operating in the pharmaceutical industry, focusing on the development and commercialization of topical and transdermal drug delivery systems. The company aims to provide innovative solutions for drug delivery, enhancing patient outcomes and addressing unmet medical needs.
Average Trading Volume: 473,079
Technical Sentiment Signal: Sell
Current Market Cap: A$5.53M
See more insights into ACR stock on TipRanks’ Stock Analysis page.